Skip to main content
. 2022 Oct 27;14(21):5280. doi: 10.3390/cancers14215280

Table 1.

Participant characteristics.

Characteristic Cirrhosis Cases HCC Cases Controls
Total N 68 94 91 a
% Male 51.5% 57.5% 57.1%
Median Age at Sample Date (Range) 54.0 (34–65) 55.5 (34–65) 56.0 (30–65)
Median Year of Serum Collection (Range) 1991 (1991–1992) 1993 (1992–1997) 1993 (1992–1996)
Median Years of Follow-up (Range) * 19.9 (7.5–20.9) 15.3 (3.6–20.8) 19.9 (2.1–20.8)
Median BMI (Range) 24.4 (17.9–32.3) 25.0 (18.4–37.6) 23.3 (18.6–33.7)
ALT, N (%)
<15 19 (27.9) 20 (21.3) 31 (34.1)
15–44 36 (52.9) 40 (42.6) 42 (46.2)
≥45 13 (19.1) 34 (36.2) 18 (19.8)
Smoking
No 51 (75.0) 54 (57.5) 64 (70.3)
Yes 17 (25.0) 40 (42.5) 27 (29.7)
Alcohol drinking
No 63 (92.7) 85 (90.4) 82 (90.1)
Yes 5 (7.3) 9 (9.6) 9 (9.9)
Family history of HCC
No 67 (98.5) 93 (98.9) 88 (96.7)
Yes 1 (1.5) 1 (1.1) 3 (3.3)
Baseline RNA positivity †
No 14 (20.6) 8 (8.5) 8 (8.8)
Yes 51 (75.0) 86 (91.5) 83 (91.2)
Median HCV RNA level at sample date 17,400 40,400 25,700
Median time to event in years (Range) 10.75 (0.37–19.02) 13.3 (2.29–21.59) -

a Three controls were double matched to cases. * Time from baseline/entry to HCC diagnosis, death, or end of study (31 December 2011), whichever came first. † Numbers do not add to total due to missing values. Abbreviations: BMI, body mass index; ALT, alanine aminotransferease; HCC, hepatocellular carcinoma.